Showing results (671-680 of 1,074) with videos related to

Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|July 28, 2022
Mid-term MRI evaluation reveals microstructural white matter alterations in COVID-19 fully recovered subjects with anosmia presentationLaura Pelizzari, Marta Cazzoli, Susanna Lipari, et al.
Therapeutic Advances in Neurological Disorders|January 14, 2015
Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for useEva Havrdova, Dana Horakova, Ivana Kovarova
Therapeutic Advances in Neurological Disorders|March 24, 2016
Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough diseaseSteven J Greenberg, Robert Zivadinov, Peterkin Lee-Kwen, et al.
Therapeutic Advances in Neurological Disorders|March 24, 2016
Fingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidenceBhupendra O Khatri
Therapeutic Advances in Neurological Disorders|November 2, 2017
Liver injury and glatiramer acetate, an uncommon association: case report and literature reviewJavier Almeida, Nuria Solà-Valls, Elisa Pose, et al.
Therapeutic Advances in Neurological Disorders|December 16, 2015
Biomechanical analysis of spasticity treatment in patients with multiple sclerosisMichael Wininger, William Craelius, Jill Settle, et al.
Therapeutic Advances in Neurological Disorders|May 3, 2016
Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registryMartin Stangel, Ralf Gold, David Pittrow, et al.
Therapeutic Advances in Neurological Disorders|May 3, 2016
Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case seriesStacey Murray, Andrew Woo
Therapeutic Advances in Neurological Disorders|May 3, 2016
Noninvasive vagus nerve stimulation in the management of cluster headache: clinical evidence and practical experienceDagny Holle-Lee, Charly Gaul
Therapeutic Advances in Neurological Disorders|July 2, 2016
Incidence, characterization, and clinical impact analysis of peginterferon beta1a immunogenicity in patients with multiple sclerosis in the ADVANCE trialJoleen T White, Scott D Newsome, Bernd C Kieseier, et al.
Pageof 108